The latest announcement is out from Elixinol Wellness ( (AU:EXL) ).
Elixinol Wellness Ltd has announced that its Annual General Meeting will be held on May 20, 2025, where the re-election of directors will be a key agenda item. The company has set a deadline of March 27, 2025, for director nominations, indicating a focus on strategic leadership and governance. This announcement is significant for stakeholders as it highlights the company’s commitment to maintaining strong corporate governance and potentially impacts its strategic direction.
More about Elixinol Wellness
Elixinol Wellness Limited is a leader in the global hemp industry, focusing on the innovation, marketing, and sale of hemp and other plant-derived food, skincare, and nutraceutical products. The company operates a vertically integrated business in Australia, offering products across human nutrition, human wellness, pet wellness, and superfood ingredients under various brands. Elixinol USA provides high-quality hemp and plant-derived nutraceutical and skincare products.
YTD Price Performance: -33.33%
Average Trading Volume: 2,726
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $4.23M
Find detailed analytics on EXL stock on TipRanks’ Stock Analysis page.